Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy

Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy

Abstract Cancer immunotherapy has achieved promising clinical progress over the recent years for its potential to treat metastatic tumors and inhibit their recurrences effectively. However, low patient response rates and dose‐limiting toxicity remain as major dilemmas for immunotherapy. Stimuli‐resp...

Full description

Bibliographic Details
Main Authors: Jin Zhang, Yandai Lin, Zhe Lin, Qi Wei, Jiaqi Qian, Renjie Ruan, Xiancai Jiang, Linxi Hou, Jibin Song, Jianxun Ding, Huanghao Yang
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Advanced Science
Subjects:
clinical translation
controlled drug release
nanotechnology
smart nanocarrier
synergistic immunotherapy
Online Access:https://doi.org/10.1002/advs.202103444

Internet

https://doi.org/10.1002/advs.202103444

Similar Items